Arzu Yay

ORCID: 0000-0002-0541-8372 · 3 papers in corpus
article 2026
Gonadotropin-Induced Molecular Alterations in Experimental Endometriosis: Downregulation of Tumor Suppressor Genes and Inflammatory Activation
·doi:10.1007/s44411-026-00510-8

Abstract Background Endometriosis is a hormonally responsive inflammatory disease with a recognized association with certain ovarian cancer subtypes. Gonadotropins are widely used in assisted reproductive technologies; however, their direct…

article 2025
The Effect of Bazedoxifene and Fulvestrant for Preventing Ovarian Hyperstimulation Syndrome: An Experimental Study
·doi:10.3390/jcm14207435

Fulvestrant and bazedoxifene may reduce OHSS severity by lowering ascites formation and weight gain. These agents could be potential therapeutic candidates for OHSS with appropriate timing and dosage.

article 2015
A Humanized Anti-Interleukin 6 Receptor Monoclonal Antibody, Tocilizumab, for the Treatment of Endometriosis in a Rat Model
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115612134

ObjectiveThe aim of this study was to investigate the efficacy of anti-interleukin 6 (IL-6) therapy in the treatment of endometriosis in a rat model.Study designAfter the peritoneal implantation of autologous endometrial tissue, 22 Wistar f…